ArticleBritish journal of cancer2017

Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.

Maria Isabella Sereni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.